Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis (PREDICT-UC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02770040
Recruitment Status : Recruiting
First Posted : May 12, 2016
Last Update Posted : July 6, 2016
University of Melbourne
Information provided by (Responsible Party):
Dr Peter De Cruz, Austin Health

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : September 2019